SPRB·85209E109·UQ·equity·Healthcare - Biotechnology-Activist
SPRB (Spruce Biosciences, Inc.) is held by 18 institutional investors as of Q4 2025. Largest holders: CITADEL ADVISORS LLC ($6.1M), WELLINGTON MANAGEMENT GROUP LLP ($5.1M), Alyeska Investment Group, L.P. ($4.5M). Net institutional sentiment: Bullish.
See how SPRB's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer